SIENTRA, INC. (NASDAQ:SIEN) Files An 8-K Submission of Matters to a Vote of Security Holders
Item5.07.
|
Submission of Matters to a Vote of Security Holders. |
The 2017 Annual General Meeting of Stockholders (the
Annual Meeting) of Sientra, Inc. (the
Company) was held on June22, 2017. As
of April24, 2017, the record date for the Annual Meeting,
19,119,747 shares of common stock were issued and outstanding and
entitled to vote at the Annual Meeting. At the Annual Meeting,
16,716,620 shares of common stock were present in person or
represented by proxy for the proposals as summarized below.
Proposal 1. Election of Directors
The Companys stockholders elected R. Scott Greer and Kevin
OBoyle, the two nominees for Class III directors, to serve on the
Companys Board of Directors until the Companys 2020 Annual
Meeting of Stockholders and until their successors are duly
elected and qualified. The final voting results are as follows:
Election of Directors
|
|
|
|
|
|||
|
|
|
|
|
Election of Directors Including Director
Exceptions
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
8,326,634 | 2,669,996 |
Proposal 2. Ratification of Independent Registered Public
Accounting Firm
The Companys stockholders ratified the selection by the Audit
Committee of the Companys Board Directors of KPMG LLP as the
Companys independent registered public accounting firm for the
year ending December31, 2017. The voting results were as follows:
|
|
|
|
|
|||
|
|
|
|
|
About SIENTRA, INC. (NASDAQ:SIEN)
Sientra, Inc. is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. The Company’s breast implants incorporate one or more differentiated technologies, including a cohesive silicone gel and texturing branded TRUE Texture. TRUE Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth.